- Home
- MTR vs HSCS Comparison
MTR vs HSCS Comparison
Compare MTR & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTR
- HSCS
- Stock Information
- Founded
- MTR 1979
- HSCS 2007
- Country
- MTR United States
- HSCS United States
- Employees
- MTR N/A
- HSCS N/A
- Industry
- MTR Oil & Gas Production
- HSCS Medical Specialities
- Sector
- MTR Energy
- HSCS Health Care
- Exchange
- MTR Nasdaq
- HSCS Nasdaq
- Market Cap
- MTR 8.6M
- HSCS 9.9M
- IPO Year
- MTR N/A
- HSCS 2022
- Fundamental
- Price
- MTR $4.58
- HSCS $2.97
- Analyst Decision
- MTR
- HSCS Strong Buy
- Analyst Count
- MTR 0
- HSCS 2
- Target Price
- MTR N/A
- HSCS $10.50
- AVG Volume (30 Days)
- MTR 16.0K
- HSCS 33.5K
- Earning Date
- MTR 01-01-0001
- HSCS 12-15-2025
- Dividend Yield
- MTR 4.48%
- HSCS N/A
- EPS Growth
- MTR N/A
- HSCS N/A
- EPS
- MTR 0.23
- HSCS N/A
- Revenue
- MTR $623,288.00
- HSCS $6,250.00
- Revenue This Year
- MTR N/A
- HSCS N/A
- Revenue Next Year
- MTR N/A
- HSCS N/A
- P/E Ratio
- MTR $19.72
- HSCS N/A
- Revenue Growth
- MTR N/A
- HSCS N/A
- 52 Week Low
- MTR $4.29
- HSCS $2.52
- 52 Week High
- MTR $10.42
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- MTR 42.77
- HSCS 44.22
- Support Level
- MTR $4.50
- HSCS $2.95
- Resistance Level
- MTR $4.69
- HSCS $3.15
- Average True Range (ATR)
- MTR 0.20
- HSCS 0.19
- MACD
- MTR 0.03
- HSCS 0.03
- Stochastic Oscillator
- MTR 47.99
- HSCS 53.62
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.